Related Experiment Video

Updated: Apr 3, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.7K

Upregulation of microRNA-224 sensitizes human cervical cells SiHa to paclitaxel

F Lin, P Wang, Y Shen

    European Journal of Gynaecological Oncology
    |September 23, 2015
    PubMed
    Abstract

    Insights

    MicroRNA-224 (miR-224) expression is downregulated by paclitaxel in cervical cancer cells. Upregulating miR-224 enhances sensitivity to paclitaxel, suggesting its potential as a therapeutic target.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Cervical cancer remains a significant global health challenge.
    • Drug resistance, particularly to chemotherapy, limits treatment efficacy.
    • MicroRNAs (miRNAs) play crucial roles in cancer development and drug response.

    Purpose of the Study:

    • To investigate the role of miR-224 in paclitaxel resistance in cervical cancer.
    • To determine if miR-224 expression levels correlate with response to paclitaxel treatment.

    Main Methods:

    • Quantitative assessment of miR-224 expression using stem-loop real-time RT-PCR.
    • Exogenous upregulation of miR-224 in SiHa cervical cancer cells via mimic transfection.
    • Evaluation of paclitaxel sensitivity using cytotoxicity assays and IC50 determination.

    Main Results:

    • Paclitaxel treatment led to significant downregulation of miR-224 in cervical cancer cells.
    • Exogenous miR-224 mimic transfection markedly increased miR-224 expression.
    • Overexpression of miR-224 significantly decreased the IC50 value, enhancing paclitaxel sensitivity (p < 0.0001).

    Conclusions:

    • miR-224 expression is inversely correlated with paclitaxel efficacy in cervical cancer.
    • miR-224 may serve as a predictive biomarker for paclitaxel response.
    • Targeting miR-224 presents a potential therapeutic strategy for overcoming paclitaxel resistance in cervical cancer.

    More Related Videos

    Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

    Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

    Published on: March 30, 2019

    8.1K
    An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

    An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

    Published on: May 21, 2019

    9.0K

    Related Concept Videos

    Drugs that Stabilize Microtubules01:15

    Drugs that Stabilize Microtubules

    Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
    2.9K
    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
    4.3K
    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
    24.7K